Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined.Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participants who met one of th...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Peter G. Gibson, Ian A. Yang, John W. Upham, Paul N. Reynolds, Sandra Hodge, Alan L. James, Christine Jenkins, Matthew Peters, Guy B. Marks, Melissa Baraket, Heather Powell, Jodie L. Simpson
Hōputu: Artigo
Reo:Ingarihi
I whakaputaina: 2019
Urunga tuihono:https://doi.org/10.1183/23120541.00056-2019
https://openres.ersjournals.com/content/erjor/5/4/00056-2019.full.pdf
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!